Indonesia International Institute for Life Sciences - Learning Resources Center

  • Home
  • Information
  • News
  • Help
  • Librarian
  • Member Area
  • Select Language :
    Arabic Bengali Brazilian Portuguese English Espanol German Indonesian Japanese Malay Persian Russian Thai Turkish Urdu

Search by :

ALL Author Subject ISBN/ISSN Advanced Search

Last search:

{{tmpObj[k].text}}
No image available for this title
Bookmark Share

Thesis

Comparison of Bioinformatics Pipeline for Enrichment Illumina Next Generation Sequencing Systems in Detecting SARS-CoV-2 Virus Strains from Yogyakarta and Central Java, Indonesia

Stefanus Bernard - Personal Name;

Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) is a newly emerging virus well known as the major cause of worldwide pandemic due to Coronavirus Disease 2019 (COVID-19). Major breakthroughs in the Next Generation Sequencing (NGS) field were elucidated following the first release of a full length SARS-CoV-2 genome in January 10th 2020, with the hope to turn the table against worsening pandemic situation. Previous studies in respiratory viruses characterization require mapping of raw sequences to the human genome in downstream bioinformatics pipeline as part of metagenomic principles. Illumina, as the major player in the NGS arena, took action by releasing guidelines of improved enrichment kits called the Respiratory Virus Oligo Panel (RVOP) based on hybridization capture method capable of capturing targeted respiratory viruses including SARS-CoV-2. Therefore, allowing direct map of raw sequences data to SARS-CoV-2 genome in downstream bioinformatics pipeline. Consequently, two bioinformatics pipelines emerged with no previous studies benchmarked the pipelines. This study focuses on gaining insight and understanding of target enrichment workflow by Illumina through utilization of different bioinformatics pipelines named as ‘Fast Pipeline’ and ‘Normal Pipeline’ to SARS-CoV-2 strains isolated from Yogyakarta and Central Java. Overall, both pipelines work well in the characterization of SARS-CoV-2 samples including in the identification of major studied nucleotide substitutions and amino acids mutations. Certain limitations were identified in terms of pipeline algorithm whereas it is highly recommended in the future studies to design a pipeline in an integrated framework, for instance by using NextFlow, a workflow framework to combine all scripts into one fully integrated pipeline.


Availability
#
Reference Collection (Bioinformatics Thesis) BI 21-001
T202109032
Available
Detail Information
Series Title
-
Call Number
BI 21-001
Publisher
Jakarta : i3L, Jakarta., 2021
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
SARS-COV-2
Next Generation Sequencing
Illumina
Bioinformatics Pipeline
Specific Detail Info
-
Statement of Responsibility
-
Other version/related

No other version available

File Attachment
No Data
Comments

You must be logged in to post a comment

Indonesia International Institute for Life Sciences - Learning Resources Center
  • Information
  • Services
  • Librarian
  • Member Area

About Us

i3L Learning Resources Center (LRC) is vital part of your academic experience at Indonesia International Institute for Life-Sciences. LRC exists to support the teaching, learning and research programs of the Institute through the provision of high quality services and facilities which include access to a range of printed and digital resources primarily in the field of life-sciences and business. 

Search

start it by typing one or more keywords for title, author or subject

Keep SLiMS Alive Want to Contribute?

© 2025 — Senayan Developer Community

Powered by SLiMS
Select the topic you are interested in
  • Computer Science, Information & General Works
  • Philosophy & Psychology
  • Religion
  • Social Sciences
  • Language
  • Pure Science
  • Applied Sciences
  • Art & Recreation
  • Literature
  • History & Geography
Icons made by Freepik from www.flaticon.com
Advanced Search
Where do you want to share?